The 7 leading NASH biotechs with major 2020 catalysts - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 66 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 51%

ایران اخبار اخبار

ایران آخرین اخبار,ایران سرفصلها

The future of these 7 biotechs hinges on their ability to treat a silent liver disease and capture a $9.6 billion market. Here's exactly what investors should be watching for this year.

There are about 70 drugs in clinical testing for NASH, a fatty liver disease that affects millions of Americans and is a top cause of liver transplants.

The other six biotechs we highlight have major clinical trial readouts set for 2020, which could prove transformative for these companies in the hunt for additional NASH therapies. Big drugmakers have faced years of costly failures in the fight to come up with treatments for the silent liver disease known as NASH."It's been such a graveyard of failures because the biology is so poorly understood," Baird analyst Brian Skorney recently told Business Insider.

Note: This list doesn't include big pharma companies with notable NASH readouts set for this year, such as Novo Nordisk's test of a diabetes drug against the liver disease. There are also some significant NASH biotechs set for a quiet 2020, such as Madrigal Pharmaceuticals, which is set to reveal data on how well its treatment works in the second part of next year.solidified its pole position in the race to market in 2019, as potential competition faltered in clinical testing.

The company said it hasn't yet seen the data, and the delay will allow Genfit to "incorporate the latest FDA insights expected by the end of March." There will be much more data to come. The company expects to provide results from a study specifically focused on the most severe NASH patients before the end of June.

 

از نظر شما متشکرم. نظر شما پس از بررسی منتشر خواهد شد.
این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:

 /  🏆 729. in İR

ایران آخرین اخبار, ایران سرفصلها

Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.

Business Insider credit card reviews: Updated for 2020 - Business InsiderAll of Business Insider's credit card reviews in one place. Read reviews of cards like the Chase Sapphire Preferred, the Delta Amex cards and more. He he he... Where is cryptocom Visa card? Up to 5% back on all card spendings + free Spotify + free Netflix + free Airport lounge + free App + $50 welcome bonus (if you stake 50MCO) Check if your email is entitled for welcome bonus
منبع: BusinessInsider - 🏆 729. / 51 ادامه مطلب »

Insider tips to navigate biggest private equity event of 2020 - Business InsiderAfter Coronavirus disrupted investors' international travel this year, thousands of private-equity execs are now jetting into Berlin, Germany, to discuss fundraising and doing deals.
منبع: BusinessInsider - 🏆 729. / 51 ادامه مطلب »

SUCESS INSIDER: McKinsey, Hilton, freelance web design, depression - Business InsiderSUCCESS INSIDER: Read the email templates a freelance web designer has used to get customer referrals and make a $200,000 salary
منبع: BusinessInsider - 🏆 729. / 51 ادامه مطلب »

Major American companies are reeling from coronavirusA growing number of major American companies — including United Airlines and Mastercard — are saying coronavirus is hurting their business. Now now they will be fine by April 'the heat will take care of it' It’s only just begun. Of course it will hurt them. Why don't they channel their resources into finding a cure rather than spreading the virus all over. When we stop thinking of only ourselves and pockets then can we save humanity .
منبع: CNN - 🏆 4. / 95 ادامه مطلب »

Key lessons from a retired Army sergeant for running a business - Business Insider5 key lessons a retired Army sergeant picked up from his 34-year military career that have guided him as a successful entrepreneur
منبع: BusinessInsider - 🏆 729. / 51 ادامه مطلب »